Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tanja Bergmann
The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-Ctla-4 Therapy in Metastatic Melanoma From the Ipilimumab Network
PLoS ONE
Multidisciplinary
Related publications
Ipilimumab: An Anti-Ctla-4 Antibody for Metastatic Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Comment on ‘Efficacy and Toxicity of Treatment With the Anti-Ctla-4 Antibody Ipilimumab in Patients With Metastatic Melanoma After Prior Anti-Pd-1 Therapy’
British Journal of Cancer
Cancer Research
Oncology
Corrigendum: Association of CTLA-4 Gene Variants With Response to Therapy and Long-Term Survival in Metastatic Melanoma Patients Treated With Ipilimumab: An Italian Melanoma Intergroup Study
Frontiers in Immunology
Allergy
Immunology
Retrospective Side Effect Profiling of the Metastatic Melanoma Combination Therapy Ipilimumab-Nivolumab Using Adverse Event Data
Diagnostics
Clinical Biochemistry
774 Analysis of the Tumor Reactivity of Tumor-Infiltrating Lymphocytes in a Metastatic Melanoma Lesion That Lost MHC Class I Expression After Anti-Pd-1 Therapy
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
The CTLA-4 X OX40 Bispecific Antibody ATOR-1015 Induces Anti-Tumor Effects Through Tumor-Directed Immune Activation
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Bevacizumab Plus Ipilimumab in Patients With Metastatic Melanoma
Cancer immunology research
Cancer Research
Immunology
Metastatic Melanoma of the Tongue: A Rare Case
Actas Dermo-Sifiliograficas
Dermatology
Forensic Medicine
Pathology
Histology
Analysis of DNA Methylation Patterns in the Tumor Immune Microenvironment of Metastatic Melanoma
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
